United States · 
Who invested in DEM BioPharma?
DEM BioPharma's investors include Insight Partners, Alexandria Venture Investments and Longwood Fund.
United States · Series A startup
Who invested in DEM BioPharma
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$70Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $70MJun 2022
- Investors
- 3
The rounds
- Jun 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list DEM BioPharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about DEM BioPharma
How much has DEM BioPharma raised?
DEM BioPharma has raised $70M across 1 round since 2022.
When did DEM BioPharma last raise?
DEM BioPharma's most recent round was a Series A of $70M in Jun 2022.
What was DEM BioPharma's biggest round?
Its most recent round, $70M in Jun 2022, is also its largest on record.
Who backed DEM BioPharma first?
DEM BioPharma's first round on record, in Jun 2022, was backed by Insight Partners, Alexandria Venture Investments and Longwood Fund.
What stage is DEM BioPharma at?
DEM BioPharma's latest named round is a Series A, in Jun 2022.
Where is DEM BioPharma based?
DEM BioPharma is based in the United States.
Companies like DEM BioPharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.